Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Furusawa

Showing results (251-260 of 257) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 257 results.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1980
[A co-operative study on prophylaxis of fungal infection in patients with hematological diseases: prophylactic effect of oral administration of amphotericin B (author's transl)]T Suda, M Omine, J Tsuchiya, et al.
International Journal of Hematology|April 4, 2000
Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemiaA Takeshita, H Saito, K Toyama, et al.
Archives of Orthopaedic and Traumatic Surgery. Archiv Fur Orthopadische Und Unfall-Chirurgie|October 1, 1979
Clinical features of 22 cases with "inter-sterno-costo-clavicular ossification". A new rheumatic syndromeH Sonozaki, A Azuma, K Okai, et al.
Ryumachi. [Rheumatism]|June 1, 1980
[Arthro-osteitis associated with pustulosis palmaris et plantaris (author's transl)]H Sonozaki, A Azuma, K Okai, et al.
Blood|July 4, 2001
Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fractionA Miyazato, S Ueno, K Ohmine, et al.
International Journal of Hematology|June 10, 2000
Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformationK Saito, Y Nakamura, M Aoyagi, et al.
The Japanese Journal of Antibiotics|April 29, 2000
[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases]A Urabe, A Fujita, K Aoki, et al.
Pageof 26

Showing results (251-260 of 257) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 257 results.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1980
[A co-operative study on prophylaxis of fungal infection in patients with hematological diseases: prophylactic effect of oral administration of amphotericin B (author's transl)]T Suda, M Omine, J Tsuchiya, et al.
International Journal of Hematology|April 4, 2000
Efficacy of a new formulation of lenograstim (recombinant glycosylated human granulocyte colony-stimulating factor) containing gelatin for the treatment of neutropenia after consolidation chemotherapy in patients with acute myeloid leukemiaA Takeshita, H Saito, K Toyama, et al.
Archives of Orthopaedic and Traumatic Surgery. Archiv Fur Orthopadische Und Unfall-Chirurgie|October 1, 1979
Clinical features of 22 cases with "inter-sterno-costo-clavicular ossification". A new rheumatic syndromeH Sonozaki, A Azuma, K Okai, et al.
Ryumachi. [Rheumatism]|June 1, 1980
[Arthro-osteitis associated with pustulosis palmaris et plantaris (author's transl)]H Sonozaki, A Azuma, K Okai, et al.
Blood|July 4, 2001
Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fractionA Miyazato, S Ueno, K Ohmine, et al.
International Journal of Hematology|June 10, 2000
Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformationK Saito, Y Nakamura, M Aoyagi, et al.
The Japanese Journal of Antibiotics|April 29, 2000
[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases]A Urabe, A Fujita, K Aoki, et al.
Pageof 26